Pages that link to "Q28269915"
Jump to navigation
Jump to search
The following pages link to Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists (Q28269915):
Displaying 50 items.
- The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer (Q21342813) (← links)
- The Role of PPARs in Cancer (Q21342955) (← links)
- DLC-1: a Rho GTPase-activating protein and tumour suppressor (Q23917637) (← links)
- Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells (Q24316364) (← links)
- The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention (Q24601222) (← links)
- The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases (Q24612698) (← links)
- Molecular Targeted Therapies of Aggressive Thyroid Cancer (Q26774734) (← links)
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review (Q26866784) (← links)
- Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer (Q27026428) (← links)
- PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs (Q28066756) (← links)
- Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis (Q28070220) (← links)
- Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders (Q28082264) (← links)
- The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines (Q28238709) (← links)
- Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms (Q28283135) (← links)
- Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells (Q28543879) (← links)
- (Q29026596) (redirect page) (← links)
- Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition (Q30498249) (← links)
- COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ (Q33317621) (← links)
- Regulatory subunits of PKA define an axis of cellular proliferation/differentiation in ovarian cancer cells (Q33372446) (← links)
- The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging (Q33540291) (← links)
- Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma (Q33575523) (← links)
- Therapeutic Implications of PPARgamma in Human Osteosarcoma (Q33674615) (← links)
- In vivo effects of rosiglitazone in a human neuroblastoma xenograft (Q33723620) (← links)
- Energy restriction as an antitumor target of thiazolidinediones (Q33744668) (← links)
- Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis (Q33830757) (← links)
- Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer (Q33837550) (← links)
- PPARγ in head and neck cancer prevention (Q33896090) (← links)
- Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver (Q34235817) (← links)
- Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin (Q34420463) (← links)
- Novel approaches in anaplastic thyroid cancer therapy (Q34458018) (← links)
- Skin phototype: a new perspective (Q34467780) (← links)
- Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer (Q34646050) (← links)
- Extensive alternative splicing of the repressor element silencing transcription factor linked to cancer (Q34685755) (← links)
- Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells (Q35051779) (← links)
- Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth (Q35092571) (← links)
- In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer (Q35168034) (← links)
- Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells (Q35249254) (← links)
- Role of traditional and new biomarkers in breast carcinogenesis. (Q35572905) (← links)
- Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. (Q35750111) (← links)
- Peroxisome proliferator activated receptor γ protein expression is asymmetrically distributed in primary lung tumor and metastatic to lung osteosarcoma samples and does not correlate with gene methylation. (Q35763145) (← links)
- PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. (Q35927161) (← links)
- Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia (Q35943219) (← links)
- Solid tumor differentiation therapy - is it possible? (Q36071880) (← links)
- Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management (Q36172739) (← links)
- Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer (Q36187022) (← links)
- The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer (Q36238973) (← links)
- Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. (Q36294936) (← links)
- Radiation-induced cognitive impairment--from bench to bedside (Q36344693) (← links)
- Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs (Q36494764) (← links)
- Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study (Q36560240) (← links)